Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708667019 | Axicabtagene ciloleucel-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708668012 | Product containing axicabtagene ciloleucel in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4616831000052115 | läkemedel som innehåller axikabtagen ciloleucel, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Axicabtagene ciloleucel-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Axicabtagene ciloleucel-containing product in parenteral dose form | Is a | Product containing axicabtagene ciloleucel (medicinal product) | true | Inferred relationship | Some | ||
| Axicabtagene ciloleucel-containing product in parenteral dose form | Has active ingredient | Axicabtagene ciloleucel (substance) | true | Inferred relationship | Some | 1 | |
| Axicabtagene ciloleucel-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Axicabtagene ciloleucel-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Axicabtagene ciloleucel only product in parenteral dose form | Is a | True | Axicabtagene ciloleucel-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR